天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

methyl (S,E)-4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)but-2-enoate

methyl (S,E)-4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)but-2-enoate Struktur
1893398-45-2
CAS-Nr.
1893398-45-2
Englisch Name:
methyl (S,E)-4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)but-2-enoate
Synonyma:
methyl (S,E)-4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)but-2-enoate;2-Butenoic acid, 4-[(3S)-3-fluoro-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-1-pyrrolidinyl]-, methyl ester, (2E)-
CBNumber:
CB514757902
Summenformel:
C19H26FN3O2
Molgewicht:
347.43
MOL-Datei:
1893398-45-2.mol

methyl (S,E)-4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)but-2-enoate Eigenschaften

Siedepunkt:
529.3±50.0 °C(predicted)
Dichte
1.22±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
pka
10.80±0.40(predicted)

Sicherheit

methyl (S,E)-4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)but-2-enoate Chemische Eigenschaften,Einsatz,Produktion Methoden

methyl (S,E)-4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)but-2-enoate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

methyl (S,E)-4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)but-2-enoate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Birdo (Shanghai) Medical Technology Co., Ltd. 021-58099077-8041 18601625411
 sales@birdotech.com China 9322 58
  • methyl (S,E)-4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)but-2-enoate
  • 2-Butenoic acid, 4-[(3S)-3-fluoro-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-1-pyrrolidinyl]-, methyl ester, (2E)-
  • 1893398-45-2
Copyright 2019 ? ChemicalBook. All rights reserved